Search for a command to run...
Risk assessment is central to modern clinical medicine, guiding prevention strategies, treatment decisions, and allocation of healthcare resources. However, most widely used risk tools are designed around single diseases or organ systems, such as cardiovascular disease, diabetes, kidney disease, or frailty. While effective within their domains, these tools provide fragmented views of health and fail to capture the systemic nature of aging and chronic disease. Patients frequently present with discordant risk profiles across systems—for example, low cardiovascular risk scores alongside significant inflammatory or metabolic dysfunction. Clinicians are therefore required to mentally integrate multiple partially overlapping metrics without a unifying biological model. This limitation becomes increasingly problematic in older adults, where morbidity and mortality are driven less by isolated diseases and more by cumulative, multi-system decline. Traditional risk scores are optimized for narrow outcomes and assume relative independence between physiological systems. Interaction effects—such as the amplification of cardiovascular risk by chronic inflammation or renal dysfunction—are typically not modeled explicitly. As a result, these tools may underestimate risk in individuals with coordinated system stress and overestimate risk when abnormalities are isolated and compensated. Systems biology offers a framework in which health is understood as the maintenance of equilibrium across interacting physiological systems. Concepts such as allostatic load, inflammaging, metabolic syndrome, and multi-morbidity reflect the recognition that disease often arises from coordinated dysregulation, not isolated failure. Biomarkers, in this view, are not independent predictors but observable manifestations of underlying system states. A clinically useful framework should therefore integrate biomarkers into a coherent representation of physiological reserve and vulnerability.